second-generation pirfenidone analogs (InterMune)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Namesecond-generation pirfenidone analogs (InterMune)

Drug Alias Namepirfenidone analog (Intermune)ITMN-14440ITMN-520ITMN-30162

ClassificationSmall molecules

Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsTransforming growth factor beta receptors antagonistsFibroblast growth factor receptors antagonists +[5]

TargetsTransforming growth factor beta receptorsFibroblast growth factor receptorsP38 α mitogen-activated protein kinase +[4]

Therapy Area/IndicationsLung Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIntermune Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIntermune Inc

Active IndicationsN/A

Inactive IndicationsLung Diseases

Other Information

ATC CodeN/A